Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update
Authors
Keywords
Brain metastasis, Targeted therapy, Immunotherapy, Radiation therapy, Chemotherapy
Journal
Current Treatment Options in Neurology
Volume 18, Issue 7, Pages -
Publisher
Springer Nature
Online
2016-05-26
DOI
10.1007/s11940-016-0416-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both?
- (2016) F. Dhermain et al. ANNALS OF ONCOLOGY
- Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
- (2016) Chee-Seng Tan et al. LUNG CANCER
- The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases
- (2016) F. Y. Moraes et al. ONCOLOGIST
- Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
- (2015) K. A. Ahmed et al. ANNALS OF ONCOLOGY
- A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer
- (2015) Yun Fan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
- (2015) Ana P. Kiess et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases
- (2015) Daniel B. Costa et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases
- (2015) Manmeet S. Ahluwalia et al. JOURNAL OF NEURO-ONCOLOGY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Comparison of Gefitinib Versus VMP in the Combination with Radiotherapy for Multiple Brain Metastases from Non-small Cell Lung Cancer
- (2014) Feng Wang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Emerging Opportunities for the Combination of Molecularly Targeted Drugs with Radiotherapy
- (2014) E.J. Searle et al. CLINICAL ONCOLOGY
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
- (2014) Vinai Gondi et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Trial of Capecitabine Concomitantly With Whole-Brain Radiotherapy Followed by Capecitabine and Sunitinib for Brain Metastases From Breast Cancer
- (2014) P. Niravath et al. ONCOLOGIST
- Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy
- (2014) Tomas Kazda et al. Radiation Oncology
- Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
- (2014) Karim Tazi et al. Cancer Medicine
- Trial Watch: Radioimmunotherapy for oncological indications
- (2014) Norma Bloy et al. OncoImmunology
- A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
- (2013) Nancy U. Lin et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumor immune responses induced by ionizing irradiation and further immune stimulation
- (2013) Benjamin Frey et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
- (2013) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy
- (2013) Imke Satzger et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer
- (2013) James W. Welsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
- (2013) Paolo A. Ascierto et al. JOURNAL OF CLINICAL ONCOLOGY
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concurrent whole brain radiotherapy and bortezomib for brain metastasis
- (2013) Christopher D Lao et al. Radiation Oncology
- Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma
- (2013) HongQing Zhuang et al. Drug Design Development and Therapy
- Vemurafenib and Radiosensitization
- (2013) Lise Boussemart et al. JAMA Dermatology
- The Biology of Brain Metastasis
- (2012) R. R. Langley et al. CLINICAL CHEMISTRY
- Targeted therapy in brain metastasis
- (2012) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Treatment of brain metastases in patients with melanoma
- (2012) Rosalie Fisher et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
- (2012) Bjørn H. Grønberg et al. LUNG CANCER
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- NRAS mutation status is an independent prognostic factor in metastatic melanoma
- (2011) John A. Jakob et al. CANCER
- A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
- (2011) Evan J. Wuthrick et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
- (2011) Gianfranco A. Pesce et al. EUROPEAN JOURNAL OF CANCER
- It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology
- (2011) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Strategizing the Clone Wars: Pharmacological Control of Cellular Sensitivity to Radiation
- (2011) R. J. Kimple MOLECULAR INTERVENTIONS
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America
- (2010) Walter M. Stadler et al. CANCER
- The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancer
- (2010) Joel W Neal Future Oncology
- Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
- (2009) Y H Park et al. BRITISH JOURNAL OF CANCER
- Phase I Study of Concurrent Whole Brain Radiotherapy and Erlotinib for Multiple Brain Metastases From Non–Small-Cell Lung Cancer
- (2009) Joline S.W. Lind et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started